PMID- 37369261 OWN - NLM STAT- MEDLINE DCOM- 20230908 LR - 20230908 IS - 1873-1597 (Electronic) IS - 1572-1000 (Linking) VI - 43 DP - 2023 Sep TI - A new perspective in the treatment follow-up of toxoplasma retinochoroiditis: Infiltrate thickness measurement. PG - 103676 LID - S1572-1000(23)00403-9 [pii] LID - 10.1016/j.pdpdt.2023.103676 [doi] AB - BACKGROUND: This study aimed to describe the spectral domain optical coherence tomography (SD-OCT) findings of active lesions in toxoplasma retinochoroiditis cases and to examine the changes in retinochoroidal infiltrate thickness after treatment. METHODS: A total of 21 newly diagnosed patients with ocular toxoplasmosis were included in this prospective study. A complete ophthalmologic examination and SD-OCT were performed at the first visit. The patients were followed up weekly, and the SD-OCT images were taken over the lesion at each visit for 6 weeks. The characteristics of the active retinochoroiditis focus at the first visit were determined, and the infiltrate thicknesses at all visits were analyzed. RESULTS: A statistically significant BCVA difference was observed at the first visit and at the last visit 6 weeks later (p < 0.01). The first week after treatment showed a significant decrease in infiltrate thickness (113.904 +/- 86.001 microm). In the following weeks, this decrease continued more softly. The thickness change at 6 weeks was significantly reduced (16.095 +/- 14.784 microm) compared with the previous ones. Weekly infitrate thickness changes were compared among themselves; a statistically significant difference was found between the 1st and 2nd weeks and the 5th and 6th weeks (p = 0.035 and p = 0.007, respectively). Detached posterior vitreous in 71% (15/21) and increased posterior vitreous thickness in 76% (16/21) of active lesion were detected. All patients had 100% (21/21) increased retinal reflectivity and disorganized retinal layers, and choroidal hypo-reflectivity was observed in 86% (18/21). CONCLUSION: SD-OCT is a useful imaging modality in the diagnosis and follow-up of ocular toxoplasmosis cases. Serial thickness measurements of toxoplasma retinochoroiditis lesions may help confirm our diagnosis and determine the need for treatment. CI - Copyright (c) 2023 Elsevier B.V. All rights reserved. FAU - Mesen, Selma AU - Mesen S AD - Turkoglu Dr. Kemal Beyazit State Hospital, Ophthalmology Department. Electronic address: drselmamesen@gmail.com. FAU - Ozer, Muhammet Derda AU - Ozer MD AD - Yeni Yuzyil University, Gaziosmanpasa Hospital Ophthalmology Department. Electronic address: muhammetderda@gmail.com. LA - eng PT - Journal Article DEP - 20230625 PL - Netherlands TA - Photodiagnosis Photodyn Ther JT - Photodiagnosis and photodynamic therapy JID - 101226123 RN - 0 (Photosensitizing Agents) SB - IM MH - Humans MH - *Toxoplasmosis, Ocular/diagnostic imaging/drug therapy MH - *Toxoplasma MH - Follow-Up Studies MH - Prospective Studies MH - *Photochemotherapy/methods MH - Photosensitizing Agents/therapeutic use MH - Tomography, Optical Coherence/methods OTO - NOTNLM OT - Infectious uveitis OT - Infiltrate thickness measurement OT - Retinal imaging OT - Spectral-domain optical coherence tomography OT - Toxoplasma retinochoroiditis EDAT- 2023/06/28 01:06 MHDA- 2023/09/08 06:43 CRDT- 2023/06/27 19:10 PHST- 2023/04/18 00:00 [received] PHST- 2023/06/23 00:00 [revised] PHST- 2023/06/23 00:00 [accepted] PHST- 2023/09/08 06:43 [medline] PHST- 2023/06/28 01:06 [pubmed] PHST- 2023/06/27 19:10 [entrez] AID - S1572-1000(23)00403-9 [pii] AID - 10.1016/j.pdpdt.2023.103676 [doi] PST - ppublish SO - Photodiagnosis Photodyn Ther. 2023 Sep;43:103676. doi: 10.1016/j.pdpdt.2023.103676. Epub 2023 Jun 25.